Cargando…

Suvorexant Poisoning in a Patient With Cirrhosis and Renal Failure

Suvorexant is a novel hypnotic that acts as an orexin-1 receptor and orexin-2 receptor antagonist. Owing to its safety and tolerability, suvorexant has recently become widely used. However, little is known about the presentation of suvorexant poisoning. Here, we describe an 83-year-old man with cirr...

Descripción completa

Detalles Bibliográficos
Autores principales: Ito, Hiroshi, Ogawa, Yasuhiro, Shimojo, Nobutake, Kawano, Satoru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8101530/
https://www.ncbi.nlm.nih.gov/pubmed/33968537
http://dx.doi.org/10.7759/cureus.14329
_version_ 1783688970545135616
author Ito, Hiroshi
Ogawa, Yasuhiro
Shimojo, Nobutake
Kawano, Satoru
author_facet Ito, Hiroshi
Ogawa, Yasuhiro
Shimojo, Nobutake
Kawano, Satoru
author_sort Ito, Hiroshi
collection PubMed
description Suvorexant is a novel hypnotic that acts as an orexin-1 receptor and orexin-2 receptor antagonist. Owing to its safety and tolerability, suvorexant has recently become widely used. However, little is known about the presentation of suvorexant poisoning. Here, we describe an 83-year-old man with cirrhosis and renal failure, who had taken 270 mg of suvorexant at the same time. After the overdose, he did not develop any symptoms other than prolonged drowsiness. He was successfully treated with supportive therapy alone. This is the first report describing suvorexant poisoning. Further reports should be accumulated to determine whether patients with suvorexant poisoning present with mild symptoms without intensive treatment.
format Online
Article
Text
id pubmed-8101530
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-81015302021-05-07 Suvorexant Poisoning in a Patient With Cirrhosis and Renal Failure Ito, Hiroshi Ogawa, Yasuhiro Shimojo, Nobutake Kawano, Satoru Cureus Emergency Medicine Suvorexant is a novel hypnotic that acts as an orexin-1 receptor and orexin-2 receptor antagonist. Owing to its safety and tolerability, suvorexant has recently become widely used. However, little is known about the presentation of suvorexant poisoning. Here, we describe an 83-year-old man with cirrhosis and renal failure, who had taken 270 mg of suvorexant at the same time. After the overdose, he did not develop any symptoms other than prolonged drowsiness. He was successfully treated with supportive therapy alone. This is the first report describing suvorexant poisoning. Further reports should be accumulated to determine whether patients with suvorexant poisoning present with mild symptoms without intensive treatment. Cureus 2021-04-06 /pmc/articles/PMC8101530/ /pubmed/33968537 http://dx.doi.org/10.7759/cureus.14329 Text en Copyright © 2021, Ito et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Emergency Medicine
Ito, Hiroshi
Ogawa, Yasuhiro
Shimojo, Nobutake
Kawano, Satoru
Suvorexant Poisoning in a Patient With Cirrhosis and Renal Failure
title Suvorexant Poisoning in a Patient With Cirrhosis and Renal Failure
title_full Suvorexant Poisoning in a Patient With Cirrhosis and Renal Failure
title_fullStr Suvorexant Poisoning in a Patient With Cirrhosis and Renal Failure
title_full_unstemmed Suvorexant Poisoning in a Patient With Cirrhosis and Renal Failure
title_short Suvorexant Poisoning in a Patient With Cirrhosis and Renal Failure
title_sort suvorexant poisoning in a patient with cirrhosis and renal failure
topic Emergency Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8101530/
https://www.ncbi.nlm.nih.gov/pubmed/33968537
http://dx.doi.org/10.7759/cureus.14329
work_keys_str_mv AT itohiroshi suvorexantpoisoninginapatientwithcirrhosisandrenalfailure
AT ogawayasuhiro suvorexantpoisoninginapatientwithcirrhosisandrenalfailure
AT shimojonobutake suvorexantpoisoninginapatientwithcirrhosisandrenalfailure
AT kawanosatoru suvorexantpoisoninginapatientwithcirrhosisandrenalfailure